Sanofi Consumer Healthcare India has informed that this is with reference to letter dated 17th February 2026, wherein meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 25th February 2026, to consider and approve the Audited Financial Statements for the Quarter and Financial Year ended 31st December 2025. In furtherance of the above, they informed Sanofi Consumer Healthcare India's Board of Directors may also consider the recommendation of dividend, if any, for the Financial Year ended 31st December 2025 at the aforesaid meeting to be held on Wednesday, 25th February 2026.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.90 |
| Dr. Reddys Lab | 1222.90 |
| Cipla | 1231.00 |
| Zydus Lifesciences | 932.25 |
| Lupin | 2327.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: